AIM: To investigate the antineoplastic potency of the novel insulin-like growth factor 1 receptor (IGF-1R) tyro- sine kinase inhibitor (TKI) NVP-AEW541 in cell
Introduction:Drugs may be an important cause of atypical lymphocytic infiltration.Often times,these infiltrates are in the context of pseudolymphomata.We report